KATALOG · NICE TECHNOLOGY APPRAISALS
924 drug appraisals, satu portal.
Telusuri seluruh Technology Appraisal (TA) dan Highly Specialised Technologies (HST) NICE — disaring per disease area, programme, dan keyword. Klik appraisal untuk membuka rekomendasi numbered + extracted methods.
924 hasil
Daftar Appraisal
- TATA1149Belantamab mafodotin with bortezomib and dexamethasone for previously treated multiple myelomaTABlood and immune system conditions2026-04-30
- TATA1147Vorasidenib for treating astrocytoma or oligodendroglioma with IDH1 or IDH2 mutations after surgery in people 12 years and overTACancermethods ✓2026-04-29
- TATA1148Sodium zirconium cyclosilicate for treating hyperkalaemiaTADiabetes and other endocrinal, nutritional and metabolic conditions2026-04-29
- TATA1146Ripretinib for treating advanced gastrointestinal stromal tumours after 3 or more kinase inhibitorsTACancermethods ✓2026-04-28
- TATA11452026-04-21
- TATA1144Subcutaneous spesolimab 1-ml formulation for preventing generalised pustular psoriasis flares in people 12 years and over (terminated appraisal)TASkin conditions2026-04-08
- TATA1143Fezolinetant for treating moderate to severe vasomotor symptoms associated with menopauseTAGynaecological conditions2026-03-31
- TATA1142Dupilumab for maintenance treatment of uncontrolled chronic obstructive pulmonary disease with raised blood eosinophilsTARespiratory conditions2026-03-26
- TATA11402026-03-17
- TATA11412026-03-17
- TATA1139Epcoritamab for treating relapsed or refractory follicular lymphoma after 2 or more lines of systemic treatmentTABlood and immune system conditions2026-03-11
- HSTHST35Pegzilarginase for treating arginase-1 deficiency in people 2 years and overHSTDiabetes and other endocrinal, nutritional and metabolic conditions2026-03-04
- TATA11382026-03-02
- TATA1136Bevacizumab (originator and biosimilars) with fluoropyrimidine-based chemotherapy for metastatic colorectal cancerTACancermethods ✓2026-02-25
- TATA1137Canagliflozin for treating type 2 diabetes in people 10 to 17 years (terminated appraisal)TADiabetes and other endocrinal, nutritional and metabolic conditions2026-02-25
- TATA1135Baloxavir marboxil for treating and preventing influenza in children 1 to 11 years (terminated appraisal)TAInfections2026-02-19
- HSTHST342026-02-18
- TATA1133Belantamab mafodotin with pomalidomide and dexamethasone for previously treated multiple myelomaTABlood and immune system conditions2026-02-18
- TATA1134Dupilumab for treating severe chronic rhinosinusitis with nasal polypsTAEar, nose and throat conditions2026-02-18
- TATA1132Ruxolitinib for treating moderate to severe chronic graft versus host disease after an allogeneic stem cell transplant in people 28 days to 17 years (terminated appraisal)TABlood and immune system conditions2026-02-17